ND
Narasimharaju Datlavenkata
About Narasimharaju Datlavenkata
Data last updated:
Narasimharaju Datlavenkata is a Director at Steel City Pharmaceuticals Pvt Ltd (since 2012), Director at Gajuwaka Pharmaceuticals Private Limited (since 2014) and Director at Ukkunagar Chits Private Limited (since 2018), and holds 4 more current directorships. The companies operate in Pharma, Financial Services and Steel. The 5 current companies with reported revenue have a combined latest revenue of ₹27.19 Cr; the largest is Steel City Pharmaceuticals Pvt Ltd at ₹15.63 Cr (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Steel City Pharmaceuticals Pvt Ltd U24239AP1993PTC016799 | Director | 28 Mar 2012 | 1993 | ₹15.63 Cr (FY 2022) | Active |
| Gajuwaka Pharmaceuticals Private Limited U24239AP2002PTC038342 | Director | 14 Mar 2014 | 2002 | ₹10.79 Cr (FY 2023) | Active |
| Ukkunagar Chits Private Limited U65992AP1998PTC029565 | Director | 25 May 2018 | 1998 | ₹48.7 Lakh (FY 2025) | Active |
| Saimadhuri Chits (Gajuwaka) Private Limited U65991AP2014PTC095022 | Director | 08 Aug 2014 | 2014 | ₹27.4 Lakh (FY 2017) | Active |
| Simhagiri Developers Private Limited U27109AP1977PTC002219 | Managing Director | 31 Mar 2017 | 1977 | ₹1 Lakh (FY 2020) | Active |
| Saimadhuri Properties Private Limited U45309AP2017PTC105304 | Managing Director | 03 Mar 2017 | 2017 | Active | |
| Designated Partner | 18 Aug 2015 | 2015 | Active |
Board colleagues of Narasimharaju Datlavenkata
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Narasimharaju Datlavenkata
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Narasimharaju Datlavenkata
Narasimharaju Datlavenkata currently holds 7 directorships: Steel City Pharmaceuticals Pvt Ltd (Director, since 28 Mar 2012, revenue ₹15.63 Cr (FY 2022)); Gajuwaka Pharmaceuticals Private Limited (Director, since 14 Mar 2014, revenue ₹10.79 Cr (FY 2023)); Ukkunagar Chits Private Limited (Director, since 25 May 2018, revenue ₹48.7 Lakh (FY 2025)); Saimadhuri Chits (Gajuwaka) Private Limited (Director, since 08 Aug 2014, revenue ₹27.4 Lakh (FY 2017)); Simhagiri Developers Private Limited (Managing Director, since 31 Mar 2017, revenue ₹1 Lakh (FY 2020)); and 2 more.
Narasimharaju Datlavenkata was first appointed on 28 Mar 2012 as Director at Steel City Pharmaceuticals Pvt Ltd. The most recent appointment on record is 25 May 2018 at Ukkunagar Chits Private Limited.
The 5 current companies of Narasimharaju Datlavenkata that report revenue have a combined latest revenue of ₹27.19 Cr: Steel City Pharmaceuticals Pvt Ltd ₹15.63 Cr (FY 2022); Gajuwaka Pharmaceuticals Private Limited ₹10.79 Cr (FY 2023); Ukkunagar Chits Private Limited ₹48.7 Lakh (FY 2025); Saimadhuri Chits (Gajuwaka) Private Limited ₹27.4 Lakh (FY 2017); Simhagiri Developers Private Limited ₹1 Lakh (FY 2020).
The current boards of Narasimharaju Datlavenkata's companies include Papa Rao Vegi (Steel City Pharmaceuticals Pvt Ltd), Rama Chandra Rao Vemulapalli (Steel City Pharmaceuticals Pvt Ltd), Satyanarayana Chaparala (Steel City Pharmaceuticals Pvt Ltd), Surya Sita Rama Raju Kakarlapudi (Steel City Pharmaceuticals Pvt Ltd), Thirupathi Rao Bommi (Steel City Pharmaceuticals Pvt Ltd), Veeru Naidu Manthini (Steel City Pharmaceuticals Pvt Ltd), among others.